What is the coverage and dosage of Doxycycline (antibiotic) for bacterial infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Doxycycline Coverage and Dosing for Bacterial Infections

Antimicrobial Spectrum

Doxycycline provides broad-spectrum coverage against gram-positive and gram-negative bacteria, atypical organisms (Mycoplasma, Chlamydia, Legionella), rickettsiae, spirochetes (Borrelia, Treponema pallidum), and certain protozoa. 1, 2, 3

Key Pathogens Covered:

  • Sexually Transmitted Infections: First-line for Chlamydia trachomatis, alternative for syphilis in penicillin-allergic non-pregnant patients, and effective against many Neisseria gonorrhoeae strains (though not recommended as first-line due to 77.2% tetracycline resistance in strains with elevated cefixime MICs) 1, 2, 4
  • Respiratory Pathogens: Effective for community-acquired pneumonia including atypical organisms, with demonstrated efficacy comparable to fluoroquinolones 5, 3
  • Intracellular Organisms: Excellent activity against Rickettsia, Ehrlichia, Mycoplasma, and Chlamydia species 3, 6, 7
  • Tick-Borne Diseases: Drug of choice for Lyme disease (Borrelia) and rickettsial infections 3, 6

Standard Dosing Regimens

Adults:

  • Loading dose: 200 mg on day 1 (100 mg every 12 hours) 8
  • Maintenance dose: 100 mg every 12 hours for most infections 8
  • Severe infections: Continue 100 mg every 12 hours rather than reducing to once daily 8
  • Some experts recommend a 200 mg first dose for pneumonia to achieve adequate serum levels more rapidly 5

Pediatric Dosing (>8 years old):

  • Children ≤100 lbs: 2 mg/lb divided into two doses on day 1, then 1 mg/lb daily (single or divided doses); up to 2 mg/lb may be used for severe infections 8
  • Children >100 lbs: Use adult dosing 8
  • Contraindicated in children <8 years (except for life-threatening infections like anthrax) due to tooth discoloration risk 1, 2

Infection-Specific Dosing

Sexually Transmitted Infections:

  • Chlamydia trachomatis: 100 mg orally twice daily for 7 days 5, 1, 2, 8
  • Nongonococcal urethritis (C. trachomatis or U. urealyticum): 100 mg orally twice daily for 7 days 8
  • Early syphilis (penicillin allergy): 100 mg orally twice daily for 2 weeks 8
  • Late syphilis (>1 year duration): 100 mg orally twice daily for 4 weeks 8
  • Gonorrhea: 100 mg orally twice daily for 7 days (only as alternative second agent with ceftriaxone when azithromycin unavailable; NOT as monotherapy) 4, 8
  • Acute epididymo-orchitis: 100 mg orally twice daily for at least 10 days 8

Pelvic Inflammatory Disease:

  • Oral regimen: Ceftriaxone 250 mg IM once PLUS doxycycline 100 mg orally twice daily for 14 days 5
  • Parenteral regimen: Ampicillin/sulbactam 3 g IV every 6 hours PLUS doxycycline 100 mg IV or orally every 12 hours; switch to oral after 24 hours of clinical improvement, continue doxycycline to complete 14 days total 5

Community-Acquired Pneumonia:

  • Outpatient without comorbidities: Doxycycline 100 mg orally twice daily (consider 200 mg first dose) 5
  • Duration: Continue for 10 days in streptococcal infections 8

Post-Exposure Prophylaxis (STI Prevention):

  • Doxy PEP: 200 mg as single dose within 72 hours after sexual contact (maximum 200 mg per 24 hours) for MSM and transgender women with bacterial STI in past 12 months 1, 2
  • Efficacy: Reduces syphilis and chlamydia by >70%, gonorrhea by ~50%; does NOT prevent Mycoplasma genitalium 1, 2

Other Infections:

  • Malaria prophylaxis: 100 mg daily (adults); 2 mg/kg daily up to adult dose (children >8 years); start 1-2 days before travel, continue during and 4 weeks after 8
  • Inhalational anthrax (post-exposure): 100 mg twice daily for 60 days 8

Pharmacokinetic Advantages

Doxycycline has superior pharmacokinetics compared to other tetracyclines: 75% oral bioavailability, ~12-hour half-life enabling twice-daily dosing, excellent tissue penetration due to lipophilicity, and no renal dose adjustment required (hepatic/intestinal elimination) 2, 3, 6

  • Food/milk does NOT significantly impair absorption (unlike other tetracyclines), though administration with food is recommended if gastric irritation occurs 8, 3
  • Administer with adequate fluids to reduce esophageal irritation and ulceration risk 8

Critical Contraindications and Precautions

Absolute Contraindications:

  • Pregnancy (all trimesters) 1, 2
  • Children <8 years (except life-threatening infections) due to permanent tooth discoloration 1, 2, 8
  • Severe hepatic dysfunction 2, 6

Common Adverse Effects:

  • Photosensitivity (advise sun protection) 1, 2
  • Gastrointestinal symptoms (nausea, diarrhea) 1, 2
  • Esophageal erosion/ulceration (take with fluids, avoid lying down immediately after) 1, 2, 8

Resistance Considerations:

  • High tetracycline resistance in N. gonorrhoeae (77.2% in strains with elevated cefixime MICs) makes doxycycline unreliable as gonorrhea monotherapy 4
  • Doxy PEP may accelerate tetracycline resistance with projected clinical lifespan of 1.6-12.1 years depending on uptake 4
  • Resistance remains low in Germany and most regions for respiratory and urinary pathogens, with ~80% therapeutic success rates 6

Clinical Pearls

  • Doxycycline is cost-effective: Oral therapy costs approximately $0.80/day (1995 data), making it an attractive alternative to fluoroquinolones and macrolides 6
  • No accumulation in renal impairment: Safe in patients with kidney disease without dose adjustment 8, 3
  • Avoid recent antibiotic class repetition: If patient recently received tetracyclines, choose different antibiotic class due to resistance risk 5
  • For tubo-ovarian abscess in PID: Many providers prefer clindamycin over doxycycline for continued therapy due to superior anaerobic coverage 5

References

Guideline

Doxycycline Coverage and Dosing for Bacterial Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Doxycycline Antimicrobial Coverage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tetracyclines.

The Medical clinics of North America, 1995

Guideline

Gonorrhea Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Doxycycline--the forgotten antibiotic].

Medizinische Klinik (Munich, Germany : 1983), 2000

Research

Doxycycline in the management of sexually transmitted infections.

The Journal of antimicrobial chemotherapy, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.